About Conference
A one-day CME-accredited conference discussing the latest advances in the management of benign and malignant hematologic disorders, emphasizing a multidisciplinary approach.
Highlights
Hematologic malignancies, regional focus, education.?
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
A garden can save your life
2.
Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.
3.
A new therapeutic approach could help tackle radiation resistance in childhood brain tumors
4.
Patients value communication skills from cancer surgeons across six key areas, according to research
5.
New surgical method shows promising results for cervical cancer treatment
1.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
2.
Polycythemia Vera: A Historical Perspective and Contemporary Management
3.
Understanding Apoplexy: Symptoms, Causes, and Treatment Options
4.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
5.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
Recommended News For You
1.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
2.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
3.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
4.
FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma
5.
In prostate cancer survivorship, sleep disturbances are underappreciated.
Conferences That Might Interest You
Recommended Articles For You
1.
The importance of understanding normal serum osmolality
2.
Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis
3.
Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology
4.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
5.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
Boost Your Knowledge With These Quizzes
1.
Quiz on Mixed Connective Tissue Disease: Can You Navigate The Diagnosis and Treatment Challenges?
2.
Quiz on Upper Respiratory Tract Infections (URTIs)
3.
Quiz on Evaluation and Treatment of Vasculitis Syndromes: Are You Updated on the Latest Diagnostic and Therapeutic Advances?
4.
Quiz on Hematological Complications of Cytokine Release Syndrome (CRS) in CAR-T Cell Therapy
5.
Quiz On Atropine Use
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge